Giuseppina Sandri Selected Research

Skin Ulcer

1/2017	Application of DoE approach in the development of mini-capsules, based on biopolymers and manuka honey polar fraction, as powder formulation for the treatment of skin ulcers.
7/2016	Particulate systems based on pectin/chitosan association for the delivery of manuka honey components and platelet lysate in chronic skin ulcers.
3/2016	Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. II. Loading of the Hemoderivative Platelet Lysate.
3/2016	Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. I. Design of Experiments-Assisted Development.
2/2014	Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties.
1/2014	Calcium alginate particles for the combined delivery of platelet lysate and vancomycin hydrochloride in chronic skin ulcers.
1/2007	Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppina Sandri Research Topics

Disease

19	Wounds and Injuries (Trauma) 02/2022 - 01/2007
7	Skin Ulcer 01/2017 - 01/2007
5	Infections 07/2019 - 01/2008
2	Wound Infection (Wound Infections) 04/2020 - 07/2019
2	Stomatitis 02/2019 - 02/2013
2	Ulcer 01/2019 - 04/2012
2	Mucositis 03/2014 - 09/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 04/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Periodontal Pocket (Periodontal Pockets) 01/2021
1	Periodontitis 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2019
1	Esophagitis 02/2019
1	Ischemia 01/2019
1	Burns 01/2019
1	Inflammation (Inflammations) 01/2019
1	Leg Ulcer 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Diabetic Foot 01/2019
1	Hemorrhage 03/2018
1	Congenital Heart Defects (Congenital Heart Defect) 02/2018
1	Atrophic Vaginitis 10/2017
1	Neoplasms (Cancer) 10/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016
1	Eye Infections 01/2016
1	Arthritis (Polyarthritis) 10/2015

Drug/Important Bio-Agent (IBA)

17	ChitosanIBA 04/2021 - 01/2007
6	Pharmaceutical PreparationsIBA 01/2019 - 01/2008
5	PowdersIBA 01/2017 - 01/2014
4	Hyaluronic Acid (Hyaluronan)IBA 04/2020 - 01/2007
4	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2020 - 02/2018
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2011
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2018 - 05/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 03/2012
3	Lipid NanoparticlesIBA 04/2021 - 05/2013
3	Biopolymers (Biopolymer)IBA 01/2021 - 01/2017
3	AlginatesIBA 12/2019 - 01/2014
3	Glutamic Acid (Glutamate)FDA Link 02/2018 - 05/2013
3	Ophthalmic Solutions (Eye Drops)IBA 01/2016 - 04/2012
2	GelatinIBA 01/2021 - 02/2018
2	PolymersIBA 11/2020 - 01/2007
2	Norfloxacin FDA Link 04/2020 - 01/2019
2	Poloxamer (Poloxamer 407)IBA 01/2019 - 03/2014
2	AntioxidantsIBA 02/2018 - 01/2007
2	Oleic Acid (Oleate)IBA 02/2018 - 01/2018
2	Sericins (Sericin)IBA 03/2016 - 03/2016
2	Vancomycin FDA LinkGeneric 01/2014 - 01/2008
1	Amino Acids FDA Link 02/2022
1	Drug CarriersIBA 11/2021
1	Sigma-1 ReceptorIBA 01/2021
1	gellan gumIBA 01/2021
1	Nylons (Nylon)IBA 11/2020
1	Biocompatible Materials (Biomaterials)IBA 11/2020
1	HydroxidesIBA 11/2020
1	hydroxide ionIBA 11/2020
1	IronIBA 11/2020
1	phenylethane boronic acid (PEBA)IBA 11/2020
1	Polysaccharides (Glycans)IBA 04/2020
1	GlycosaminoglycansIBA 07/2019
1	SilverIBA 07/2019
1	ClayIBA 01/2019
1	Bentonite (Montmorillonite)IBA 01/2019
1	Dosage Forms (Dosage Form)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Sulfadiazine (Sulphadiazine)FDA Link 02/2018
1	Tocopherols (Tocopherol)IBA 02/2018
1	alpha-Tocopherol FDA Link 02/2018
1	Eucalyptus OilIBA 01/2018
1	Olive OilIBA 01/2018
1	LipidsIBA 01/2018
1	Volatile Oils (Essential Oils)IBA 01/2018
1	PolyphenolsIBA 10/2017
1	OligosaccharidesIBA 01/2017
1	PectinsIBA 07/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	Excipients (Suspending Agents)IBA 01/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016
1	chitosan lactateIBA 03/2014
1	GelsIBA 03/2014
1	GlycerophosphatesIBA 03/2014
1	platelet-derived growth factor ABIBA 01/2014
1	Silver CompoundsIBA 05/2013
1	CelluloseIBA 05/2013
1	SolutionsIBA 02/2013
1	UCON 50-HB-5100 (F127)IBA 09/2011
1	carbopol 940 (sodium polyacrylate)IBA 02/2011
1	gamma-cyclodextrinIBA 01/2008
1	CyclodextrinsIBA 01/2008
1	ChlorhexidineIBA 01/2007

Therapy/Procedure

6	Therapeutics 02/2018 - 01/2007
1	Drug-Eluting Stents 07/2021
1	Drug Therapy (Chemotherapy) 02/2019
1	Radiotherapy 02/2019